Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Clinical trial NCT00953576 · TERMINATED
Trial details
- NCT number
- NCT00953576
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-29
- Primary completion
- 2013-04-11
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.